IRMD
Price
$86.58Alerts
Change
-$0.14 (-0.16%)
Updated
Nov 11 closing price
Capitalization
1.1B
84 days until earnings call
Intraday BUY SELL Signals
NPCE
Price
$12.52Alerts
Change
-$0.17 (-1.34%)
Updated
Nov 11 closing price
Capitalization
429.05M
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

IRMD vs NPCE

IRMD vs NPCE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IRMD vs. NPCE commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRMD is a StrongBuy and NPCE is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for IRMD with price predictions
Nov 11, 2026

IRMD's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for IRMD turned positive on November 06, 2026. Looking at past instances where IRMD's MACD turned positive, the stock continued to rise in 42 of 53 cases over the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IRMD's RSI Oscillator exited the oversold zone, 12 of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on IRMD as a result. In 86 of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

IRMD moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in 194 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

IRMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 203 of 260 cases where IRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for IRMD crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.847) is normal, around the industry mean (4.142). P/E Ratio (47.685) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.180) is also within normal values, averaging (11.253). Dividend Yield (0.009) settles around the average of (0.011) among similar stocks. P/S Ratio (12.315) is also within normal values, averaging (40.124).

A.I.Advisor
a Summary for NPCE with price predictions
Nov 11, 2026

Momentum Indicator for NPCE turns negative, indicating new downward trend

NPCE saw its Momentum Indicator move below the 0 level on November 10, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 98 similar instances where the indicator turned negative. In 88 of the 98 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NPCE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

NPCE broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NPCE entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NPCE's RSI Oscillator exited the oversold zone, 23 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 56 cases where NPCE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for NPCE just turned positive on November 04, 2026. Looking at past instances where NPCE's MACD turned positive, the stock continued to rise in 38 of 46 cases over the following month. The odds of a continued upward trend are 83%.

Following a +0.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where NPCE advanced for three days, in 236 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NPCE's P/B Ratio (36.106) is slightly higher than the industry average of (4.142). P/E Ratio (-21.930) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (4.427) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. NPCE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NPCE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
IRMD: Fundamental Ratings
IRMD
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
20
SMR RATING
1..100
41
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
55
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRMDNPCE
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 17 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
85%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (IRMD: $86.58 vs. NPCE: $12.52)
Brand notoriety: IRMD and NPCE are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: IRMD: 50% vs. NPCE: 76%
Market capitalization -- IRMD: $1.1B vs. NPCE: $429.05M
IRMD [@Medical/Nursing Services] is valued at $1.1B. NPCE’s [@Medical/Nursing Services] market capitalization is $429.05M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRMD’s FA Score shows that 1 FA rating(s) are green while NPCE’s FA Score has 2 green FA rating(s).

  • IRMD’s FA Score: 1 green, 4 red.
  • NPCE’s FA Score: 2 green, 3 red.
According to our system of comparison, IRMD is a better buy in the long-term than NPCE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRMD’s TA Score shows that 7 TA indicator(s) are bullish while NPCE’s TA Score has 4 bullish TA indicator(s).

  • IRMD’s TA Score: 7 bullish, 3 bearish.
  • NPCE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IRMD is a better buy in the short-term than NPCE.

Price Growth

IRMD (@Medical/Nursing Services) experienced а -2.26% price change this week, while NPCE (@Medical/Nursing Services) price change was -6.15% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.

Reported Earning Dates

IRMD is expected to report earnings on Feb 04, 2027.

NPCE is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with PHG. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then PHG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
-0.16%
PHG - IRMD
48%
Loosely correlated
-0.69%
HBIO - IRMD
45%
Loosely correlated
+4.54%
ATEC - IRMD
44%
Loosely correlated
+5.00%
LIVN - IRMD
43%
Loosely correlated
-0.18%
TCMD - IRMD
42%
Loosely correlated
+1.92%
More

NPCE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NPCE has been loosely correlated with LIVN. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NPCE jumps, then LIVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPCE
1D Price
Change %
NPCE100%
-1.34%
LIVN - NPCE
54%
Loosely correlated
-0.18%
OFIX - NPCE
43%
Loosely correlated
+0.84%
IRMD - NPCE
42%
Loosely correlated
-0.16%
IART - NPCE
41%
Loosely correlated
+1.65%
UFPT - NPCE
39%
Loosely correlated
+0.00%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEIS231.609.91
+4.47%
Advanced Energy Industries
ATS17.650.40
+2.32%
ATS Corp
CULP3.56-0.01
-0.28%
Culp
CCAP10.25-0.13
-1.25%
Crescent Capital BDC
FTAIM26.50-0.35
-1.30%
FTAI Aviation Ltd